Journal articleMol Cancer Res2019
Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition.
- Journal
- Mol Cancer Res
- Published
- 5 August 2019
- Citations
- 45
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 4
- Gastrointestinal Cancer P30CA056036↗
- The role of wild-type KRAS in the context of tumor profession and metastasis R01CA178445↗
- Targeting HuR to improve a synthetic lethal therapy for pancreatic cancer R01CA212600↗
- The Development And Progression Of IPMN To PDA In The Context Of Inactivated Activin Signaling R01CA217207↗